Skip to main content

Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate

Abstract

We have studied the effect of androgenic deprivation on the level of androgen receptor transcript in the rat ventral prostate. The rats were treated with estradiol benzoate, flutamide and [D Trp6, des Gly10]gonadotropin releasing hormone (GnRH) for different time periods. These treatments produced a significant decrease in the weight of prostate. Total RNA isolated from the ventral prostates was hybridized with the cDNA probe for androgen receptor. Densitometric analysis of the autoradiographic signal revealed a rise in the level of androgen receptor RNA following treatment of rats with estradiol benzoate and flutamide. Treatment of rats with [D Trp6, des Gly10] GnRH brought about a transient rise in the level of androgen receptor RNA. Thus, our results indicate that androgenic deprivation up-regulates the level of androgen receptor transcript.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83: 835–839, 1995

    Google Scholar 

  2. 2.

    Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M, Martin MB: Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2: 1157–1162, 1988

    Google Scholar 

  3. 3.

    Alexander IE, Clarke CL, Shine J, Sutherland RL. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells, Mol Endocrinol 3: 1377–1386, 1989

    Google Scholar 

  4. 4.

    Okret S, Poellinger L, Dong Y, Gustafsson JA: Down regulation of glucocorticoid receptor mRNA by the glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc Natl Acad Sci USA 83: 5899–5903, 1986

    Google Scholar 

  5. 5.

    Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM: Autologous down regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4: 22–28, 1990

    Google Scholar 

  6. 6.

    Blok LJ, Mackenbach P, Trapman J, Themmen APN, Brinkmann AO, Grootegoed JA: Follicle-stimulating hormone regulates androgen receptor mRNA in sertoli cells. Mol Cell Endocrinol 63: 267–271, 1989

    Google Scholar 

  7. 7.

    Reiter E, Bonnet P, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G. Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol 88: 77–87, 1992

    Google Scholar 

  8. 8.

    Shan L-X, Rodriguez MC, Janne OA: Regulation of androgen receptor protein and mRNA concentrations by androgens in rat ventral prostate and seminal vesicles and in human hepatoma cells. Mol Endocrinol 4: 1636–1646, 1990

    Google Scholar 

  9. 9.

    Prins GS, Woodham C: Autologous regulation of androgen receptor messenger ribonucleic acid in the separate lobes of the rat prostate gland. Biol Reprod 53: 609–619, 1995

    Google Scholar 

  10. 10.

    Zhuang YH, Blauer M, Pekki A, Tuohimaa P: Subcellular location of androgen receptor in rat prostate, seminal vesicle and human osteosarcoma MG-63 cells. J Steroid Biochem Molec Biol 41: 693–696, 1992

    Google Scholar 

  11. 11.

    Varriale B, Serino I: The androgen receptor mRNA is up regulated by testosterone in both the harderian gland and thumb pad of the frog, Rana esculenta. J Steroid Biochem Molec Biol 51: 259–265, 1994

    Google Scholar 

  12. 12.

    Mooradian AD, Morley JE, Korenman SG: Biological actions of androgens. Endocr Rev 8: 1–28, 1987

    Google Scholar 

  13. 13.

    Supakar PC, Song CS, Jung MH, Slomczynska MA, Kim JM, Vellanoweth RL, Chatterjee B, Roy AK: A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J Biol Chem 268: 26400–26408, 1993

    Google Scholar 

  14. 14.

    Kumar VL, Wadhwa SN, Kumar V, Farooq A: Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate. J Surg Oncol 44: 122–128, 1990

    Google Scholar 

  15. 15.

    Daneshgari F, Crawford D: Endocrine therapy of advanced carcinoma of the prostate Cancer 71: 1089–1097, 1993

    Google Scholar 

  16. 16.

    Lepor H, Ross A, Walsh PC: The influence of hormonal therapy on survival of men with advanced prostatic cancer. J Urol 128: 335–340, 1982

    Google Scholar 

  17. 17.

    Auffray C, Rougeon F: Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303–314, 1980

    Google Scholar 

  18. 18.

    Hsu C-YJ, Komm BS, Lyttle CR, Frankel F: Cloning of estrogen regulated messenger ribonucleic acids from rat uterus. Endocrinology 122: 631–639, 1988

    Google Scholar 

  19. 19.

    Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning–A Laboratory Manual, Vol I. Cold Spring Harbor Laboratory Press, New York, 1989, pp 7.3–7.57

    Google Scholar 

  20. 20.

    Kumar VL, Majumder PK: Prostate gland: structure, functions and regulation. Int Urol Nephrol 27: 231–243, 1995

    Google Scholar 

  21. 21.

    Forti G, Salerno R, Moneti G, Zoppi S, Fiorelli G, Marinoni T, Natali A, Costantini A, Serio M, Martini L, Motta M: Three month treatment with a long acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: Effects on tissue androgen concentration, 5 α-reductase activity and androgen receptor content. J Clin Endocrinol Metab 68: 461–468, 1988

    Google Scholar 

  22. 22.

    Stamey TA, McNeal JE: Adenocarcinoma of the prostate. In: PC Walsh, AB Retik, TA Stamey and ED Vaughan (eds). Campbell's Urology, Vol I. WS Saunders Company, Philadelphia, 1992, pp 1210–1214

    Google Scholar 

  23. 23.

    Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9: 401–406, 1995

    Google Scholar 

  24. 24.

    Ruizeveld de Winter JA, Janssen PJA, Sleddens HMEB, Verleun-Mooijman MCT, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, Vanderkwast TH: Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144: 735–746, 1994

    Google Scholar 

  25. 25.

    Lawson D, Bruchovsky N, Rennie PS, Goldenberg SL, Fletcher T:. Relative effectiveness of androgen withdrawal therapies as measured by changes in the intracellular distributions of androgen receptors and dihydrotestosterone. In: F Bresciani, RJB King, ME Lippman and JP Raynaud (eds). Progress in Cancer Research and Therapy: Hormones and Cancer. Raven Press, New York, 1988, pp 488–495

    Google Scholar 

  26. 26.

    Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271–321, 1995

    Google Scholar 

  27. 27.

    Fuqua SAW: Estrogen receptor mutagenesis and hormone resistance. Cancer 74: 1026–1029, 1994

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Vijay L. Kumar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kumar, V.L., Majumder, P.K. & Kumar, V. Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate. Mol Cell Biochem 171, 133–138 (1997). https://doi.org/10.1023/A:1006805503284

Download citation

  • androgen receptor
  • mRNA
  • prostate
  • androgen deprivation
  • receptor regulation